Back to HomeBeta

ICD-10 Coding for Lymph Node Metastasis(C77.0, C77.1)

Complete ICD-10-CM coding and documentation guide for Lymph Node Metastasis. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Metastatic LymphadenopathySecondary Lymph Node Cancer

Related ICD-10 Code Ranges

Complete code families applicable to Lymph Node Metastasis

C77-C79Primary Range

Secondary malignant neoplasms

This range includes codes for secondary malignant neoplasms, including lymph nodes, which are crucial for coding metastasis.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C77.0Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neckUse when metastasis to cervical lymph nodes is confirmed.
  • Biopsy confirmation of metastatic cancer in cervical lymph nodes
  • Imaging showing lymph node enlargement
C77.1Secondary and unspecified malignant neoplasm of intrathoracic lymph nodesUse for confirmed metastasis to intrathoracic lymph nodes.
  • CT scan showing enlarged intrathoracic lymph nodes
  • Histological confirmation of metastasis

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for lymph node metastasis

Essential facts and insights about Lymph Node Metastasis

Lymph node metastasis is coded using C77.x codes, specifying the site of metastasis. Primary cancer should also be coded.

Primary ICD-10-CM Codes for lymph node metastasis

Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck
Billable Code

Decision Criteria

clinical Criteria

  • Biopsy confirms metastatic cancer in lymph nodes

Applicable To

  • Metastasis to cervical lymph nodes

Excludes

  • Primary malignant neoplasm of lymph nodes (C81-C96)

Clinical Validation Requirements

  • Biopsy confirmation of metastatic cancer in cervical lymph nodes
  • Imaging showing lymph node enlargement

Code-Specific Risks

  • Misidentifying primary vs. secondary neoplasm

Coding Notes

  • Ensure primary site is documented if known.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Encounter for antineoplastic chemotherapy

Z51.11
Use when patient is receiving chemotherapy for metastatic cancer.

Encounter for antineoplastic radiation therapy

Z51.0
Use when patient is receiving radiation therapy for metastatic cancer.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Hodgkin lymphoma, nodular sclerosis

C81.0
Primary neoplasm vs. secondary metastasis

Secondary malignant neoplasm of lung

C78.0
Lung tissue involvement vs. lymph node involvement

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Lymph Node Metastasis to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C77.0.

Impact

Clinical: Misrepresentation of patient's current treatment status., Regulatory: Potential non-compliance with coding standards., Financial: Incorrect billing and potential claim denials.

Mitigation Strategy

Verify current treatment status before coding., Use active treatment codes when applicable.

Impact

Reimbursement: Incorrect sequencing can lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.

Mitigation Strategy

Always sequence the code for the site of metastasis first when treatment is directed at the metastatic site.

Impact

Incorrect sequencing of primary and secondary codes.

Mitigation Strategy

Regular training on sequencing rules.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Lymph Node Metastasis, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Lymph Node Metastasis

Use these documentation templates to ensure complete and accurate documentation for Lymph Node Metastasis. These templates include all required elements for proper coding and billing.

Metastatic cancer treatment

Specialty: Oncology

Required Elements

  • Primary cancer site
  • Metastatic site
  • Treatment plan

Example Documentation

Patient with metastatic adenocarcinoma to periaortic lymph nodes, primary ascending colon. Plan: FOLFOX chemotherapy.

Examples: Poor vs. Good Documentation

Poor Documentation Example
History of cancer, lymph node involvement.
Good Documentation Example
Metastatic adenocarcinoma to left axillary lymph nodes, primary ovarian carcinoma.
Explanation
The good example specifies the primary site and metastatic location, providing clarity.

Need help with ICD-10 coding for Lymph Node Metastasis? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more